30 Mar 2022 In-Depth Analysis: Broncus (2216 HK, BUY): FY21 revenue above consensus by 13% FY21 net loss of US$236m larger than consensus of US$34m due to one-off expenses of US$199m. FY21 revenue grew by 234% to US$11m driven by China sales increasing 375% y-o-y following easing of COVID-19. Valuation now extremely attractive as the […]

Read more of this post